Mustang Bio, Inc. (MBIO)
NASDAQ: MBIO · Real-Time Price · USD
0.754
-0.006 (-0.79%)
Apr 28, 2026, 4:00 PM EDT - Market closed
Mustang Bio Employees
Mustang Bio had 4 employees as of December 31, 2025. The number of employees decreased by 2 or -33.33% compared to the previous year.
Employees
4
Change (1Y)
-2
Growth (1Y)
-33.33%
Revenue / Employee
n/a
Profits / Employee
-$480,250
Market Cap
5.71M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| CollPlant Biotechnologies | 39 |
| Aptevo Therapeutics | 33 |
| Cardio Diagnostics Holdings | 17 |
| BioRestorative Therapies | 14 |
| XTL Biopharmaceuticals | 10 |
| Purple Biotech | 10 |
| Ernexa Therapeutics | 7 |
| Alpha Compute | 4 |
MBIO News
- 10 months ago - Dow Dips 1%; Mustang Bio Shares Spike Higher - Benzinga
- 10 months ago - Mustang Bio Granted Orphan Drug Designation by U.S. FDA for MB-101 (IL13Ra2-targeted CAR T-cells) to Treat Astrocytomas and Glioblastoma - GlobeNewsWire
- 1 year ago - Mustang Bio Regains Compliance with Nasdaq Capital Market Requirement - GlobeNewsWire
- 1 year ago - Mustang Bio Announces Sale of Fixed Assets and Exit of Facility - GlobeNewsWire
- 1 year ago - Mustang Bio Regains Compliance with Nasdaq Minimum Bid Price Requirement - GlobeNewsWire
- 1 year ago - Mustang Bio Announces Closing of $8 Million Public Offering - GlobeNewsWire
- 1 year ago - Mustang Bio Announces Pricing of $8 Million Public Offering - GlobeNewsWire
- 1 year ago - Mustang Bio Announces Reverse Stock Split - GlobeNewsWire